Glaukos Announces Participation in Stephens Investor Conference
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the Stephens Investor Conference on Wednesday, November 13, 2019, at 2:30 p.m. CST in Nashville, TN. A live audio webcast for this event will be available in the Investors section of the Glaukos websit